Literature DB >> 12781561

Interferons in relapsing remitting multiple sclerosis.

Richard A Rudick, Diane L Cookfair, Jack Griffin, Stephen Hauser, Steven Piantadosi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12781561     DOI： 10.1016/S0140-6736(03)13421-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Disease-modifying therapy in MS: a critical review of the literature. Part I: Analysis of clinical trial errors.

Authors:  Douglas S Goodin
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 2.  Interferons in relapsing-remitting multiple sclerosis: are there benefits from long-term use?

Authors:  Oscar Fernández
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Approved Beta interferons in relapsing-remitting multiple sclerosis: is there an odd one out?

Authors:  Alexis Clapin
Journal:  J Cent Nerv Syst Dis       Date:  2012-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.